Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

A.G. Florek; B. Nardone; S. Thareja; G. Tran; F.J. Giles; D.P. West

doi:10.1111/bjd.15752

Malignancies and ustekinumab: an analysis of the U.S. Food and Drug Administration Adverse Event Reporting System and the European Union Drug Regulating Authorities Pharmacovigilance database

British Journal of Dermatology ◽

10.1111/bjd.15752 ◽

2017 ◽

Vol 177 (5) ◽

Cited By ~ 10

Author(s):

A.G. Florek ◽

B. Nardone ◽

S. Thareja ◽

G. Tran ◽

F.J. Giles ◽

...

Keyword(s):

European Union ◽

Adverse Event ◽

Drug Administration ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

The European Union ◽

Event Reporting ◽

Pharmacovigilance Database ◽

The U.S

Download Full-text

Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the U.S.: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”

BioDrugs ◽

10.1007/s40259-021-00476-9 ◽

2021 ◽

Author(s):

Joerg Putzke ◽

Scott Haughie ◽

Kelly H. Zou ◽

Gopinath M. Ranganna

Keyword(s):

Adverse Event ◽

Supportive Care ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Disproportionality Analysis ◽

Event Reporting ◽

The U.S

Download Full-text

Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel

American Journal of Hematology ◽

10.1002/ajh.26246 ◽

2021 ◽

Author(s):

Graça M. Dores ◽

Christopher Jason ◽

Manette T. Niu ◽

Silvia Perez‐Vilar

Keyword(s):

Adverse Event ◽

Adverse Events ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The U.S

Download Full-text

Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Expert Opinion on Drug Safety ◽

10.1080/14740338.2017.1323867 ◽

2017 ◽

Vol 16 (7) ◽

pp. 761-767 ◽

Cited By ~ 27

Author(s):

Yasser M. Alatawi ◽

Richard A. Hansen

Keyword(s):

Adverse Event ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Empirical Estimation ◽

Event Reporting ◽

The U.S

Download Full-text

Injection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting System

Diabetes Spectrum ◽

10.2337/diaspect.28.4.283 ◽

2015 ◽

Vol 28 (4) ◽

pp. 283-288 ◽

Cited By ~ 6

Author(s):

S. C. Jones ◽

D. L. Ryan ◽

V. S. W. Pratt ◽

A. Niak ◽

A. D. Brinker

Keyword(s):

Adverse Event ◽

Injection Site ◽

Drug Administration ◽

Extended Release ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The U.S

Download Full-text

Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Epilepsy Research ◽

10.1016/j.eplepsyres.2017.06.007 ◽

2017 ◽

Vol 135 ◽

pp. 71-78 ◽

Cited By ~ 11

Author(s):

Md. Motiur Rahman ◽

Yasser Alatawi ◽

Ning Cheng ◽

Jingjing Qian ◽

Annya V. Plotkina ◽

...

Keyword(s):

Adverse Event ◽

Antiepileptic Drug ◽

Drug Administration ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

Drug Adverse Event ◽

Reporting Rates ◽

The U.S

Download Full-text

Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)

Expert Opinion on Drug Safety ◽

10.1080/14740338.2019.1562546 ◽

2018 ◽

Vol 18 (2) ◽

pp. 145-152 ◽

Cited By ~ 1

Author(s):

Shahariar Mohammed Fahim ◽

Ahmed Ullah Mishuk ◽

Ning Cheng ◽

Richard Hansen ◽

Angela I. Calderón ◽

...

Keyword(s):

Adverse Event ◽

Dietary Supplements ◽

Anticancer Drugs ◽

Drug Administration ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Botanical Dietary Supplements ◽

Event Reporting ◽

The U.S

Download Full-text

Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System

American Journal of Hematology ◽

10.1002/ajh.26454 ◽

2022 ◽

Author(s):

Graça M. Dores ◽

Afrouz Nayernama ◽

Connie Cheng ◽

Charlotte Moureaud ◽

S. Christopher Jones

Keyword(s):

Adverse Event ◽

Hemolytic Anemia ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The U.S

Download Full-text

Adverse Event Profile of Tigecycline: Data Mining of the Public Version of the U.S. Food and Drug Administration Adverse Event Reporting System

Biological and Pharmaceutical Bulletin ◽

10.1248/bpb.35.967 ◽

2012 ◽

Vol 35 (6) ◽

pp. 967-970 ◽

Cited By ~ 31

Author(s):

Kaori Kadoyama ◽

Toshiyuki Sakaeda ◽

Akiko Tamon ◽

Yasushi Okuno

Keyword(s):

Data Mining ◽

Adverse Event ◽

Drug Administration ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Adverse Event Profile ◽

Event Reporting ◽

The Public ◽

The U.S

Download Full-text

Does HIF-PHI increased risk of gastrointestinal hemorrhage in patients with renal anemia: a review of cases reported to the U.S. Food and drug administration adverse event reporting system

Renal Failure ◽

10.1080/0886022x.2021.1952881 ◽

2021 ◽

Vol 43 (1) ◽

pp. 1170-1171

Author(s):

Yangzhong Zhou ◽

Qidong Ren ◽

Rongrong Hu ◽

Ke Zheng ◽

Yan Qin ◽

...

Keyword(s):

Adverse Event ◽

Drug Administration ◽

Gastrointestinal Hemorrhage ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Renal Anemia ◽

Event Reporting ◽

Increased Risk ◽

The U.S

Download Full-text

Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.14728 ◽

2017 ◽

Vol 32 (8) ◽

pp. 1373-1376 ◽

Cited By ~ 3

Author(s):

A.K. Gupta ◽

J. Carviel ◽

M.A. Gupta ◽

N.H. Shear

Keyword(s):

Adverse Event ◽

Sexual Dysfunction ◽

Drug Administration ◽

Reporting System ◽

Food And Drug Administration ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Event Reporting ◽

The U.S

Download Full-text